tiprankstipranks
Definium Therapeutics (DFTX)
NASDAQ:DFTX
US Market
Want to see DFTX full AI Analyst Report?

Definium Therapeutics (DFTX) Blogger Opinions & Sentiment

2,242 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
DFTX Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
60% SeekingAlpha
20% Zacks
20% MotleyFool
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Definium: 'Strong Buy' Maintained On Several Anticipated 2026 Milestones
SeekingAlpha
MindMed a new buy at Jones on promise of psychedelics for mental illnesses
SeekingAlpha
5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026
Zacks
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of DFTX?
Seeking Alpha’s Terry Chrisomalis has a Bullish Sentiment.
    What do Motley Fool contributors think of DFTX?
    Currently there's no blogger sentiment for DFTX.
    What Is DFTX’s Blogger Sentiment?
    DFTX’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for DFTX?
      The most recent blogger prediction for DFTX was made by Terry Chrisomalis, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          PRRUFImmutep Ltd
          PBIGFParadigm Biopharmaceuticals
          NURPFNeuren Pharmaceuticals Limited
          MEOBFMesoblast Limited
          PRNAFAlterity Therapeutics